TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Octapharma AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 2,084,988 | 1,788,092 | 1,886,239 |
Financial expenses | 11,947 | 6,196 | 3,850 |
Earnings before taxes | 84,381 | 76,554 | 84,222 |
EBITDA | 312,079 | 320,653 | 385,133 |
Total assets | 1,409,079 | 1,785,902 | 1,731,233 |
Current assets | 444,974 | 754,986 | 569,135 |
Current liabilities | 359,203 | 270,156 | 269,861 |
Equity capital | 1,020,582 | 952,997 | 891,842 |
- share capital | 25,000 | 25,000 | 25,000 |
Employees (average) | 984 | 882 | 888 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 72.4% | 53.4% | 51.5% |
Turnover per employee | 2,119 | 2,027 | 2,124 |
Profit as a percentage of turnover | 4.0% | 4.3% | 4.5% |
Return on assets (ROA) | 6.8% | 4.6% | 5.1% |
Current ratio | 123.9% | 279.5% | 210.9% |
Return on equity (ROE) | 8.3% | 8.0% | 9.4% |
Change turnover | 296,896 | -98,147 | -80,348 |
Change turnover % | 17% | -5% | -4% |
Chg. No. of employees | 102 | -6 | 54 |
Chg. No. of employees % | 12% | -1% | 6% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.